A significant breakthrough in cancer study is emerging with the use of mini-antibodies to re-engage damaged p53. This essential tumor inhibitor protein is frequently inactivated in various forms of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research